Back to results
RecruitingPhase 1Phase 2

Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study)

NCT07142044

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California Davis

Sacramento, California, United States

Contact

William K Schmidt, PhD

650-438-3018wkschmidt@eicosis.com
View on ClinicalTrials.gov
Safety, Tolerability and Exploratory Efficacy of EC5026 in Parkinson's Disease (STEP Study) — TrialFind